Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Antibiotic-resistant germs are among the most important medical threats of our day and age. ▷ Find out more about our mission to tackle this challenge!

News

News YahooFinance 25 days ago
BioVersys to Present at H.C. Wainwright 28th Annual Global Investment Conference
BASEL, SWITZERLAND - September 3, 2026 (NEWMEDIAWIRE) - BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infection...
Read more
Report
Press release The Manila Times 5 months ago
BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026
BASEL, Switzerland, April 15, 2026 (GLOBE NEWSWIRE) --
Read more
Report
Press release The Manila Times 6 months ago
BioVersys Reports Corporate Highlights and Financial Results for the Full Year 2025
Ad hoc announcement pursuant to Art. 53 LR
Read more
Report
News YahooFinance 6 months ago
BioVersys to Report Its Full Year 2025 Financial Results, Provide a Business Update and Host a Conference Call
BASEL, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) -- BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
2
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Guangzhou China
Regional office
Guangzhou BioversysPharmaceutical Co., Ltd.
Unit 202-51, 2/F, No.6. Luoxuan San Road, International Bio-Island, Huangpu District, Guangzhou, Guangdong, China
company site
Lille France
Regional office
BIOVERSYS SAS
1 rue du Professeur Calmette, 59000 Lille, France
company site

Financials

Total raised
$8.1M
Latest round
Grant
Funding rounds
3
Funding rounds
Round Announced Amount
Grant 2019 $302k Details
Grant 2019 $7.5M Details
Grant 2017 $286k Details